Vaxcyte, Inc. - PCVX

About Gravity Analytica
Recent News
- 04.07.2025 - Needham 24th Annual Virtual Healthcare Conference
- 04.07.2025 - Needham 24th Annual Virtual Healthcare Conference
- 03.31.2025 - Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call
- 03.31.2025 - Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call
- 03.31.2025 - Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
- 03.31.2025 - Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
- 03.30.2025 - Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
- 03.30.2025 - Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
- 03.12.2025 - Jefferies Biotech on the Beach Summit
- 03.12.2025 - Jefferies Biotech on the Beach Summit
Recent Filings
- 03.31.2025 - 8-K Current report
- 03.31.2025 - EX-99.1 EX-99.1
- 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.05.2025 - 144 Report of proposed sale of securities
- 03.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 03.03.2025 - 144 Report of proposed sale of securities